These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8706033)

  • 1. Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice.
    Reitmair AH; Redston M; Cai JC; Chuang TC; Bjerknes M; Cheng H; Hay K; Gallinger S; Bapat B; Mak TW
    Cancer Res; 1996 Aug; 56(16):3842-9. PubMed ID: 8706033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse models for hereditary nonpolyposis colorectal cancer.
    de Wind N; Dekker M; van Rossum A; van der Valk M; te Riele H
    Cancer Res; 1998 Jan; 58(2):248-55. PubMed ID: 9443401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.
    Reitmair AH; Cai JC; Bjerknes M; Redston M; Cheng H; Pind MT; Hay K; Mitri A; Bapat BV; Mak TW; Gallinger S
    Cancer Res; 1996 Jul; 56(13):2922-6. PubMed ID: 8674041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice.
    Song J; Sohn KJ; Medline A; Ash C; Gallinger S; Kim YI
    Cancer Res; 2000 Jun; 60(12):3191-9. PubMed ID: 10866310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2(-/-)Rb(+/-) mice.
    Nikitin AY; Liu CY; Flesken-Nikitin A; Chen CF; Chen PL; Lee WH
    Cancer Res; 2002 Sep; 62(18):5134-8. PubMed ID: 12234974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy.
    Campbell MR; Nation PN; Andrew SE
    Cancer Res; 2005 Apr; 65(7):2626-35. PubMed ID: 15805259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MSH2 deficient mice are viable and susceptible to lymphoid tumours.
    Reitmair AH; Schmits R; Ewel A; Bapat B; Redston M; Mitri A; Waterhouse P; Mittrücker HW; Wakeham A; Liu B
    Nat Genet; 1995 Sep; 11(1):64-70. PubMed ID: 7550317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors.
    Kohonen-Corish MR; Daniel JJ; te Riele H; Buffinton GD; Dahlstrom JE
    Cancer Res; 2002 Apr; 62(7):2092-7. PubMed ID: 11929830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Muir-Torre syndrome and familial colorectal cancer: 2 families with molecular genetic analysis].
    Doré MX; Dieumegard B; Grandjouan S; Avril MF; Martinet C; Ducreux M; Lasser P; Bressac-de Paillerets B
    Ann Dermatol Venereol; 1999; 126(8-9):582-6. PubMed ID: 10530344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.
    Losi L; Di Gregorio C; Pedroni M; Ponti G; Roncucci L; Scarselli A; Genuardi M; Baglioni S; Marino M; Rossi G; Benatti P; Maffei S; Menigatti M; Roncari B; Ponz de Leon M
    Am J Gastroenterol; 2005 Oct; 100(10):2280-7. PubMed ID: 16181381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of intestinal and mammary neoplasia by lifetime administration of aspirin in Apc(Min/+) and Apc(Min/+), Msh2(-/-) mice.
    Sansom OJ; Stark LA; Dunlop MG; Clarke AR
    Cancer Res; 2001 Oct; 61(19):7060-4. PubMed ID: 11585736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
    Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
    Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Base transitions dominate the mutational spectrum of a transgenic reporter gene in MSH2 deficient mice.
    Andrew SE; Reitmair AH; Fox J; Hsiao L; Francis A; McKinnon M; Mak TW; Jirik FR
    Oncogene; 1997 Jul; 15(2):123-9. PubMed ID: 9244348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice.
    Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
    Oncogene; 2007 Jun; 26(30):4415-27. PubMed ID: 17297472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of HNPCC-related missense mutations in MSH2.
    Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
    Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA mismatch repair and colorectal cancer.
    Toft NJ; Arends MJ
    J Pathol; 1998 Jun; 185(2):123-9. PubMed ID: 9713337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
    Yao CC; Lin CY; Hu MB
    Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC).
    Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M
    Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.